Genelux SVP Sells Small Stake as Company Seeks Fresh Capital and Names New CMO
Genelux Corporation reported an insider sale by Yu Yong, SVP of Clinical Development, who sold 906 shares on March 24, 2026, to satisfy estimated taxes tied to restricted stock units. The transaction occurred as the company moves forward with a priced public offering intended to raise roughly $20 million and after appointing a new chief medical off…